Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001558370-25-011396
Filing Date
2025-08-13
Accepted
2025-08-13 16:36:50
Documents
21

Document Format Files

Seq Description Document Type Size
1 S-3 pmn-20250812xs3.htm S-3 605611
2 EX-1.2 pmn-20250812xex1d2.htm EX-1.2 269676
3 EX-4.3 pmn-20250812xex4d3.htm EX-4.3 316181
4 EX-5.1 pmn-20250812xex5d1.htm EX-5.1 50922
5 EX-5.2 pmn-20250812xex5d2.htm EX-5.2 15125
6 EX-23.1 pmn-20250812xex23d1.htm EX-23.1 4945
7 EX-FILING FEES pmn-20250812xexfees.htm   iXBRL EX-FILING FEES 37762
8 GRAPHIC pmn-20250812xex5d1001.jpg GRAPHIC 4713
9 GRAPHIC pmn-20250812xex5d2001.jpg GRAPHIC 3048
10 GRAPHIC pmn-20250812xs3001.jpg GRAPHIC 4538
11 GRAPHIC pmn-20250812xs3003.jpg GRAPHIC 6299
  Complete submission text file 0001558370-25-011396.txt   1467429

Data Files

Seq Description Document Type Size
23 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20250812xexfees_htm.xml XML 10367
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-289577 | Film No.: 251212279
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)